Natixis’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
90,666
-564,361
| -86% | -$9.77M | 0.01% | 516 |
|
|
2025
Q1 | $14.8M | Sell |
655,027
-215,600
| -25% | -$4.86M | 0.08% | 168 |
|
|
2024
Q4 | $27.8M | Buy |
+870,627
| New | +$27.8M | 0.17% | 94 |
|
|
2024
Q2 | – | Sell |
-1,339
| Closed | -$78.7K | – | 977 |
|
|
2024
Q1 | $78.7K | Sell |
1,339
-90,719
| -99% | -$5.33M | ﹤0.01% | 777 |
|
|
2023
Q4 | $5.51M | Buy |
92,058
+83,558
| +983% | +$5M | 0.04% | 269 |
|
|
2023
Q3 | $323K | Buy |
+8,500
| New | +$323K | ﹤0.01% | 650 |
|
|
2023
Q2 | – | Sell |
-15,700
| Closed | -$1.04M | – | 1005 |
|
|
2023
Q1 | $1.04M | Sell |
15,700
-329,300
| -95% | -$21.7M | 0.01% | 506 |
|
|
2022
Q4 | $17.8M | Buy |
345,000
+63,000
| +22% | +$3.26M | 0.1% | 175 |
|
|
2022
Q3 | $19.3M | Sell |
282,000
-32,000
| -10% | -$2.19M | 0.09% | 169 |
|
|
2022
Q2 | $14.2M | Buy |
314,000
+45,900
| +17% | +$2.08M | 0.05% | 230 |
|
|
2022
Q1 | $13.6M | Buy |
+268,100
| New | +$13.6M | 0.05% | 341 |
|
|
2021
Q4 | – | Sell |
-216,500
| Closed | -$7.14M | – | 1218 |
|
|
2021
Q3 | $7.14M | Buy |
216,500
+107,300
| +98% | +$3.54M | 0.02% | 445 |
|
|
2021
Q2 | $6.9M | Buy |
+109,200
| New | +$6.9M | 0.03% | 333 |
|